Target intelligence / Profile preview

Zinc finger protein 219 (ZNF219)

Target
ZNF219
Molecular classification
Transcription factor, Zinc finger protein, Kruppel-like zinc finger family
01

Overview

Zinc finger protein 219 (ZNF219) is a Kruppel-like zinc finger protein that contains nine C2H2-type zinc finger domains and acts as a transcription factor in humans[1][3]. ZNF219 generally functions as a context-dependent regulator of gene transcription, acting as a transcriptional repressor for some targets such as high mobility group nucleosome binding domain 1 (HMGN1), and as a transcriptional activator in complex with other proteins, notably enhancing SOX9-mediated chondrogenic gene expression[1][3]. ZNF219 recognizes and binds to specific DNA sequences (e.g., GGGGG and CCCCCA motifs), can be localized in the nucleus, and participates in the regulation of genes important for cartilage development and potentially other developmental processes[1][2][3]. Disease associations include frontonasal dysplasia 1 and multiple epiphyseal dysplasia[3]. There are no direct reports of small molecule drugs or therapeutic agents specifically targeting ZNF219, and its primary described function is in gene regulation, not as a classical therapeutic target such as a receptor or enzyme[1][3][4].

Other names
ZNF219ZFP219ZN219_HUMANzinc finger protein 219
02

Biological functions

Transcriptional repressionTranscriptional activation (context-dependent)Regulation of gene expressionChondrocyte differentiationDNA bindingRNA polymerase II cis-regulatory region sequence-specific DNA binding
03

Disease associations

Frontonasal dysplasia 1Epiphyseal dysplasia, multiple, 1Potential role in multicellular organism developmentRegulation of neurotransmitter levels (based on pathway annotation)

Beyond the preview

Go deeper on Zinc finger protein 219 (ZNF219).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 219 (ZNF219).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call